ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1229

Diagnosing Prosthetic Joint Infections in Patients with Inflammatory Arthritis

Serene Z. Mirza1, Shawn Richardson2, Cynthia Kahlenberg2, Jason Blevins2, Michelle Demetres3, Lily Martin3, Jackie Szymonifka2, Peter K. Sculco4, Mark P. Figgie5 and Susan M. Goodman2, 1Rheumatology, Hospital for Special Surgery, New York, NY, 2Hospital for Special Surgery, New York, NY, 3Weill Cornell Medicine, New York, NY, 4Orthopaedic Surgery, Hospital for Special Surgery/Weill Cornell Medicine, New York, NY, 5Surgery, Hospital for Special Surgery, New York, NY

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Diagnostic Tests, Infection, inflammatory arthritis, synovial cells, synovial fluid and total joint replacement

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, October 22, 2018

Title: Infection-related Rheumatic Disease Poster

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Patients with inflammatory arthritis (IA) are at increased risk of prosthetic joint infections, yet differentiating between septic and aseptic failure is a  challenge in patients with IA. Synovial fluid biomarkers, may be helpful for detection of PJI. The aim of our systematic review is to evaluate synovial fluid biomarkers and their efficacy at diagnosing PJI in patients with IA. 

Methods: A comprehensive literature search was performed in the following databases from inception – January 2018: Ovid MEDLINE, Ovid EMBASE, and The Cochrane Library . Studies retrieved were screened for eligibility against predefined criteria. Searches across the databases retrieved 367 results. After de-duplication, 2 of  5 (SM, CK, SR, JB, SG) independently screened a total of 298 citations. Discrepancies were resolved by a 3rd reviewer. After review of titles and abstracts, full text articles were  pulled for further screening and data extraction. 20 articles were included.  in this review. Due to methodological differences findings could not be pooled for meta-analysis. 5 studies that specifically investigated PJI in IA patients and non-IA patients were included and used to derive optimal cut points for common synovial tests.

Results: Our final analysis included 1435 non-IA aseptic patients, 426 non-IA septic patients, 64 IA aseptic patients and 26 IA septic patients. There was a significant difference in detection amongst the four groups when using %PMN, WBC, serum CRP and ESR, synovial IL-6, IL-8, IL-1b and CRP (Table 1). Median values of WBC count, IL-6, IL-8, and serum CRP were significantly higher in patients with IA, and although sensitivity was high, specificity was low (Table 2). PMN% had the highest sensitivity (95.2%) and specificity (85.0%) to detect infections with a threshold of optimum sensitivity and specificity of 78%.

Conclusion: Few studies address the diagnosis of PJI in patients with inflammatory arthritis  and no synovial biomarker demonstrates high sensitivity and specificity.  .  In contrast to PJI in patients with OA, we did not find synovial WBC count to be sensitive or specific in diagnosing PJI in IA patients. While diagnostic tests for synovial WBC, IL-6, IL8 and serum CRP appear higher in patients with inflammatory arthritis, there is overlap with those who are not infected. Further studies are needed to explore diagnostics tests that will better detect PJI in patients with IA


Disclosure: S. Z. Mirza, None; S. Richardson, None; C. Kahlenberg, None; J. Blevins, None; M. Demetres, None; L. Martin, None; J. Szymonifka, None; P. K. Sculco, Lima, 5; M. P. Figgie, None; S. M. Goodman, Roche, Novartis, 4.

To cite this abstract in AMA style:

Mirza SZ, Richardson S, Kahlenberg C, Blevins J, Demetres M, Martin L, Szymonifka J, Sculco PK, Figgie MP, Goodman SM. Diagnosing Prosthetic Joint Infections in Patients with Inflammatory Arthritis [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/diagnosing-prosthetic-joint-infections-in-patients-with-inflammatory-arthritis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/diagnosing-prosthetic-joint-infections-in-patients-with-inflammatory-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology